Effect of Hydralazine on Alzheimer's Disease

Condition:   Alzheimer Disease Interventions:   Drug: Hydralazine hydrochloride 25mg tablets;   Drug: Placebo Sponsors:   Shahid Sadoughi University of Medical Sciences and Health Services;   National Institute for Medical Research Development (NIMAD), Iran;   McMaster University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials